Armstrong Advisory Group
UTHR icon

Armstrong Advisory Group’s United Therapeutics UTHR Stock Holding History

Armstrong Advisory Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$542 Buy
+1
New +$517 ﹤0.01% 1010

Other funds holding UTHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Armstrong Advisory Group's UTHR Position: Q3 2026 in Review

Armstrong Advisory Group opened a new position in United Therapeutics (UTHR) in Q3 2026: 1 share worth $542. The stake represents ﹤0.01% of the portfolio and ranks #1010 among its holdings.

673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Armstrong Advisory Group held 1 share of United Therapeutics worth $542 as of Q3 2026.
  • United Therapeutics was a new Armstrong Advisory Group position in Q3 2026.
  • United Therapeutics made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #1010 holding.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.